Pharma & Healthcare
Global Bacteria-derived Microbial Drugs Market Research Report 2025
- Sep 24, 25
- ID: 521071
- Pages: 106
- Figures: 98
- Views: 5
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteria-derived Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteria-derived Microbial Drugs.
The Bacteria-derived Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteria-derived Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteria-derived Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacteria-derived Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacteria-derived Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Bacteria-derived Microbial Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteria-derived Microbial Drugs.
The Bacteria-derived Microbial Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteria-derived Microbial Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bacteria-derived Microbial Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Segment by Type
Oral Dosage Form
Enteric Capsules
Segment by Application
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bacteria-derived Microbial Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bacteria-derived Microbial Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bacteria-derived Microbial Drugs Market Overview
1.1 Product Definition
1.2 Bacteria-derived Microbial Drugs by Type
1.2.1 Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Bacteria-derived Microbial Drugs by Application
1.3.1 Global Bacteria-derived Microbial Drugs Market Value by Application (2024 VS 2031)
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Global Bacteria-derived Microbial Drugs Market Size Estimates and Forecasts
1.4.1 Global Bacteria-derived Microbial Drugs Revenue 2020-2031
1.4.2 Global Bacteria-derived Microbial Drugs Sales 2020-2031
1.4.3 Global Bacteria-derived Microbial Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bacteria-derived Microbial Drugs Market Competition by Manufacturers
2.1 Global Bacteria-derived Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bacteria-derived Microbial Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bacteria-derived Microbial Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bacteria-derived Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Product Type & Application
2.7 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Date of Enter into This Industry
2.8 Global Bacteria-derived Microbial Drugs Market Competitive Situation and Trends
2.8.1 Global Bacteria-derived Microbial Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bacteria-derived Microbial Drugs Players Market Share by Revenue
2.8.3 Global Bacteria-derived Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bacteria-derived Microbial Drugs Market Scenario by Region
3.1 Global Bacteria-derived Microbial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bacteria-derived Microbial Drugs Sales by Region: 2020-2031
3.2.1 Global Bacteria-derived Microbial Drugs Sales by Region: 2020-2025
3.2.2 Global Bacteria-derived Microbial Drugs Sales by Region: 2026-2031
3.3 Global Bacteria-derived Microbial Drugs Revenue by Region: 2020-2031
3.3.1 Global Bacteria-derived Microbial Drugs Revenue by Region: 2020-2025
3.3.2 Global Bacteria-derived Microbial Drugs Revenue by Region: 2026-2031
3.4 North America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.4.1 North America Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.4.3 North America Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.5.1 Europe Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.5.3 Europe Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacteria-derived Microbial Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Bacteria-derived Microbial Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.7.1 Latin America Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.7.3 Latin America Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacteria-derived Microbial Drugs Sales by Type (2020-2031)
4.1.1 Global Bacteria-derived Microbial Drugs Sales by Type (2020-2025)
4.1.2 Global Bacteria-derived Microbial Drugs Sales by Type (2026-2031)
4.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2020-2031)
4.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2020-2031)
4.2.1 Global Bacteria-derived Microbial Drugs Revenue by Type (2020-2025)
4.2.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2026-2031)
4.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Bacteria-derived Microbial Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bacteria-derived Microbial Drugs Sales by Application (2020-2031)
5.1.1 Global Bacteria-derived Microbial Drugs Sales by Application (2020-2025)
5.1.2 Global Bacteria-derived Microbial Drugs Sales by Application (2026-2031)
5.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2020-2031)
5.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2020-2031)
5.2.1 Global Bacteria-derived Microbial Drugs Revenue by Application (2020-2025)
5.2.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2026-2031)
5.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Bacteria-derived Microbial Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Company Information
6.1.2 Seres Therapeutics Description and Business Overview
6.1.3 Seres Therapeutics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seres Therapeutics Bacteria-derived Microbial Drugs Product Portfolio
6.1.5 Seres Therapeutics Recent Developments/Updates
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Company Information
6.2.2 Assembly Biosciences Description and Business Overview
6.2.3 Assembly Biosciences Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Assembly Biosciences Bacteria-derived Microbial Drugs Product Portfolio
6.2.5 Assembly Biosciences Recent Developments/Updates
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Company Information
6.3.2 Synthetic Biologics Description and Business Overview
6.3.3 Synthetic Biologics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthetic Biologics Bacteria-derived Microbial Drugs Product Portfolio
6.3.5 Synthetic Biologics Recent Developments/Updates
6.4 Interxon
6.4.1 Interxon Company Information
6.4.2 Interxon Description and Business Overview
6.4.3 Interxon Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Interxon Bacteria-derived Microbial Drugs Product Portfolio
6.4.5 Interxon Recent Developments/Updates
6.5 PureTech
6.5.1 PureTech Company Information
6.5.2 PureTech Description and Business Overview
6.5.3 PureTech Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PureTech Bacteria-derived Microbial Drugs Product Portfolio
6.5.5 PureTech Recent Developments/Updates
6.6 Synlogic
6.6.1 Synlogic Company Information
6.6.2 Synlogic Description and Business Overview
6.6.3 Synlogic Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synlogic Bacteria-derived Microbial Drugs Product Portfolio
6.6.5 Synlogic Recent Developments/Updates
6.7 Enterome BioScience
6.7.1 Enterome BioScience Company Information
6.7.2 Enterome BioScience Description and Business Overview
6.7.3 Enterome BioScience Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enterome BioScience Bacteria-derived Microbial Drugs Product Portfolio
6.7.5 Enterome BioScience Recent Developments/Updates
6.8 4D Pharma
6.8.1 4D Pharma Company Information
6.8.2 4D Pharma Description and Business Overview
6.8.3 4D Pharma Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 4D Pharma Bacteria-derived Microbial Drugs Product Portfolio
6.8.5 4D Pharma Recent Developments/Updates
6.9 Second Genome
6.9.1 Second Genome Company Information
6.9.2 Second Genome Description and Business Overview
6.9.3 Second Genome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Second Genome Bacteria-derived Microbial Drugs Product Portfolio
6.9.5 Second Genome Recent Developments/Updates
6.10 AOBiome
6.10.1 AOBiome Company Information
6.10.2 AOBiome Description and Business Overview
6.10.3 AOBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AOBiome Bacteria-derived Microbial Drugs Product Portfolio
6.10.5 AOBiome Recent Developments/Updates
6.11 Rebiotix
6.11.1 Rebiotix Company Information
6.11.2 Rebiotix Description and Business Overview
6.11.3 Rebiotix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rebiotix Bacteria-derived Microbial Drugs Product Portfolio
6.11.5 Rebiotix Recent Developments/Updates
6.12 Metabiomics
6.12.1 Metabiomics Company Information
6.12.2 Metabiomics Description and Business Overview
6.12.3 Metabiomics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Metabiomics Bacteria-derived Microbial Drugs Product Portfolio
6.12.5 Metabiomics Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Symberix
6.14.1 Symberix Company Information
6.14.2 Symberix Description and Business Overview
6.14.3 Symberix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Symberix Bacteria-derived Microbial Drugs Product Portfolio
6.14.5 Symberix Recent Developments/Updates
6.15 OpenBiome
6.15.1 OpenBiome Company Information
6.15.2 OpenBiome Description and Business Overview
6.15.3 OpenBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 OpenBiome Bacteria-derived Microbial Drugs Product Portfolio
6.15.5 OpenBiome Recent Developments/Updates
6.16 Azitra
6.16.1 Azitra Company Information
6.16.2 Azitra Description and Business Overview
6.16.3 Azitra Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Azitra Bacteria-derived Microbial Drugs Product Portfolio
6.16.5 Azitra Recent Developments/Updates
6.17 Osel
6.17.1 Osel Company Information
6.17.2 Osel Description and Business Overview
6.17.3 Osel Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Osel Bacteria-derived Microbial Drugs Product Portfolio
6.17.5 Osel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacteria-derived Microbial Drugs Industry Chain Analysis
7.2 Bacteria-derived Microbial Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacteria-derived Microbial Drugs Production Mode & Process Analysis
7.4 Bacteria-derived Microbial Drugs Sales and Marketing
7.4.1 Bacteria-derived Microbial Drugs Sales Channels
7.4.2 Bacteria-derived Microbial Drugs Distributors
7.5 Bacteria-derived Microbial Drugs Customer Analysis
8 Bacteria-derived Microbial Drugs Market Dynamics
8.1 Bacteria-derived Microbial Drugs Industry Trends
8.2 Bacteria-derived Microbial Drugs Market Drivers
8.3 Bacteria-derived Microbial Drugs Market Challenges
8.4 Bacteria-derived Microbial Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Bacteria-derived Microbial Drugs by Type
1.2.1 Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral Dosage Form
1.2.3 Enteric Capsules
1.3 Bacteria-derived Microbial Drugs by Application
1.3.1 Global Bacteria-derived Microbial Drugs Market Value by Application (2024 VS 2031)
1.3.2 Gastrointestinal Disorders
1.3.3 Autoimmune Disorders
1.3.4 Diabetes
1.3.5 Cancer
1.3.6 Others
1.4 Global Bacteria-derived Microbial Drugs Market Size Estimates and Forecasts
1.4.1 Global Bacteria-derived Microbial Drugs Revenue 2020-2031
1.4.2 Global Bacteria-derived Microbial Drugs Sales 2020-2031
1.4.3 Global Bacteria-derived Microbial Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Bacteria-derived Microbial Drugs Market Competition by Manufacturers
2.1 Global Bacteria-derived Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Bacteria-derived Microbial Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Bacteria-derived Microbial Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Bacteria-derived Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Product Type & Application
2.7 Global Key Manufacturers of Bacteria-derived Microbial Drugs, Date of Enter into This Industry
2.8 Global Bacteria-derived Microbial Drugs Market Competitive Situation and Trends
2.8.1 Global Bacteria-derived Microbial Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Bacteria-derived Microbial Drugs Players Market Share by Revenue
2.8.3 Global Bacteria-derived Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Bacteria-derived Microbial Drugs Market Scenario by Region
3.1 Global Bacteria-derived Microbial Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Bacteria-derived Microbial Drugs Sales by Region: 2020-2031
3.2.1 Global Bacteria-derived Microbial Drugs Sales by Region: 2020-2025
3.2.2 Global Bacteria-derived Microbial Drugs Sales by Region: 2026-2031
3.3 Global Bacteria-derived Microbial Drugs Revenue by Region: 2020-2031
3.3.1 Global Bacteria-derived Microbial Drugs Revenue by Region: 2020-2025
3.3.2 Global Bacteria-derived Microbial Drugs Revenue by Region: 2026-2031
3.4 North America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.4.1 North America Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.4.3 North America Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.5.1 Europe Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.5.3 Europe Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bacteria-derived Microbial Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Bacteria-derived Microbial Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.7.1 Latin America Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.7.3 Latin America Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Bacteria-derived Microbial Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Bacteria-derived Microbial Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bacteria-derived Microbial Drugs Sales by Type (2020-2031)
4.1.1 Global Bacteria-derived Microbial Drugs Sales by Type (2020-2025)
4.1.2 Global Bacteria-derived Microbial Drugs Sales by Type (2026-2031)
4.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2020-2031)
4.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2020-2031)
4.2.1 Global Bacteria-derived Microbial Drugs Revenue by Type (2020-2025)
4.2.2 Global Bacteria-derived Microbial Drugs Revenue by Type (2026-2031)
4.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Bacteria-derived Microbial Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Bacteria-derived Microbial Drugs Sales by Application (2020-2031)
5.1.1 Global Bacteria-derived Microbial Drugs Sales by Application (2020-2025)
5.1.2 Global Bacteria-derived Microbial Drugs Sales by Application (2026-2031)
5.1.3 Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2020-2031)
5.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2020-2031)
5.2.1 Global Bacteria-derived Microbial Drugs Revenue by Application (2020-2025)
5.2.2 Global Bacteria-derived Microbial Drugs Revenue by Application (2026-2031)
5.2.3 Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Bacteria-derived Microbial Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Seres Therapeutics
6.1.1 Seres Therapeutics Company Information
6.1.2 Seres Therapeutics Description and Business Overview
6.1.3 Seres Therapeutics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Seres Therapeutics Bacteria-derived Microbial Drugs Product Portfolio
6.1.5 Seres Therapeutics Recent Developments/Updates
6.2 Assembly Biosciences
6.2.1 Assembly Biosciences Company Information
6.2.2 Assembly Biosciences Description and Business Overview
6.2.3 Assembly Biosciences Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Assembly Biosciences Bacteria-derived Microbial Drugs Product Portfolio
6.2.5 Assembly Biosciences Recent Developments/Updates
6.3 Synthetic Biologics
6.3.1 Synthetic Biologics Company Information
6.3.2 Synthetic Biologics Description and Business Overview
6.3.3 Synthetic Biologics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Synthetic Biologics Bacteria-derived Microbial Drugs Product Portfolio
6.3.5 Synthetic Biologics Recent Developments/Updates
6.4 Interxon
6.4.1 Interxon Company Information
6.4.2 Interxon Description and Business Overview
6.4.3 Interxon Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Interxon Bacteria-derived Microbial Drugs Product Portfolio
6.4.5 Interxon Recent Developments/Updates
6.5 PureTech
6.5.1 PureTech Company Information
6.5.2 PureTech Description and Business Overview
6.5.3 PureTech Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 PureTech Bacteria-derived Microbial Drugs Product Portfolio
6.5.5 PureTech Recent Developments/Updates
6.6 Synlogic
6.6.1 Synlogic Company Information
6.6.2 Synlogic Description and Business Overview
6.6.3 Synlogic Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Synlogic Bacteria-derived Microbial Drugs Product Portfolio
6.6.5 Synlogic Recent Developments/Updates
6.7 Enterome BioScience
6.7.1 Enterome BioScience Company Information
6.7.2 Enterome BioScience Description and Business Overview
6.7.3 Enterome BioScience Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enterome BioScience Bacteria-derived Microbial Drugs Product Portfolio
6.7.5 Enterome BioScience Recent Developments/Updates
6.8 4D Pharma
6.8.1 4D Pharma Company Information
6.8.2 4D Pharma Description and Business Overview
6.8.3 4D Pharma Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 4D Pharma Bacteria-derived Microbial Drugs Product Portfolio
6.8.5 4D Pharma Recent Developments/Updates
6.9 Second Genome
6.9.1 Second Genome Company Information
6.9.2 Second Genome Description and Business Overview
6.9.3 Second Genome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Second Genome Bacteria-derived Microbial Drugs Product Portfolio
6.9.5 Second Genome Recent Developments/Updates
6.10 AOBiome
6.10.1 AOBiome Company Information
6.10.2 AOBiome Description and Business Overview
6.10.3 AOBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 AOBiome Bacteria-derived Microbial Drugs Product Portfolio
6.10.5 AOBiome Recent Developments/Updates
6.11 Rebiotix
6.11.1 Rebiotix Company Information
6.11.2 Rebiotix Description and Business Overview
6.11.3 Rebiotix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Rebiotix Bacteria-derived Microbial Drugs Product Portfolio
6.11.5 Rebiotix Recent Developments/Updates
6.12 Metabiomics
6.12.1 Metabiomics Company Information
6.12.2 Metabiomics Description and Business Overview
6.12.3 Metabiomics Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Metabiomics Bacteria-derived Microbial Drugs Product Portfolio
6.12.5 Metabiomics Recent Developments/Updates
6.13 Ritter Pharmaceuticals
6.13.1 Ritter Pharmaceuticals Company Information
6.13.2 Ritter Pharmaceuticals Description and Business Overview
6.13.3 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product Portfolio
6.13.5 Ritter Pharmaceuticals Recent Developments/Updates
6.14 Symberix
6.14.1 Symberix Company Information
6.14.2 Symberix Description and Business Overview
6.14.3 Symberix Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Symberix Bacteria-derived Microbial Drugs Product Portfolio
6.14.5 Symberix Recent Developments/Updates
6.15 OpenBiome
6.15.1 OpenBiome Company Information
6.15.2 OpenBiome Description and Business Overview
6.15.3 OpenBiome Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 OpenBiome Bacteria-derived Microbial Drugs Product Portfolio
6.15.5 OpenBiome Recent Developments/Updates
6.16 Azitra
6.16.1 Azitra Company Information
6.16.2 Azitra Description and Business Overview
6.16.3 Azitra Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Azitra Bacteria-derived Microbial Drugs Product Portfolio
6.16.5 Azitra Recent Developments/Updates
6.17 Osel
6.17.1 Osel Company Information
6.17.2 Osel Description and Business Overview
6.17.3 Osel Bacteria-derived Microbial Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Osel Bacteria-derived Microbial Drugs Product Portfolio
6.17.5 Osel Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bacteria-derived Microbial Drugs Industry Chain Analysis
7.2 Bacteria-derived Microbial Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bacteria-derived Microbial Drugs Production Mode & Process Analysis
7.4 Bacteria-derived Microbial Drugs Sales and Marketing
7.4.1 Bacteria-derived Microbial Drugs Sales Channels
7.4.2 Bacteria-derived Microbial Drugs Distributors
7.5 Bacteria-derived Microbial Drugs Customer Analysis
8 Bacteria-derived Microbial Drugs Market Dynamics
8.1 Bacteria-derived Microbial Drugs Industry Trends
8.2 Bacteria-derived Microbial Drugs Market Drivers
8.3 Bacteria-derived Microbial Drugs Market Challenges
8.4 Bacteria-derived Microbial Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bacteria-derived Microbial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bacteria-derived Microbial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bacteria-derived Microbial Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Bacteria-derived Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bacteria-derived Microbial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bacteria-derived Microbial Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bacteria-derived Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacteria-derived Microbial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteria-derived Microbial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacteria-derived Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bacteria-derived Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Bacteria-derived Microbial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Bacteria-derived Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Bacteria-derived Microbial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Bacteria-derived Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bacteria-derived Microbial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Bacteria-derived Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bacteria-derived Microbial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bacteria-derived Microbial Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Bacteria-derived Microbial Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Bacteria-derived Microbial Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Bacteria-derived Microbial Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Bacteria-derived Microbial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Bacteria-derived Microbial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Bacteria-derived Microbial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Interxon Bacteria-derived Microbial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. PureTech Bacteria-derived Microbial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Synlogic Bacteria-derived Microbial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Bacteria-derived Microbial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 4D Pharma Bacteria-derived Microbial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Second Genome Bacteria-derived Microbial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AOBiome Bacteria-derived Microbial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rebiotix Bacteria-derived Microbial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Metabiomics Bacteria-derived Microbial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Symberix Bacteria-derived Microbial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. OpenBiome Bacteria-derived Microbial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Azitra Bacteria-derived Microbial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Osel Bacteria-derived Microbial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Bacteria-derived Microbial Drugs Distributors List
Table 158. Bacteria-derived Microbial Drugs Customers List
Table 159. Bacteria-derived Microbial Drugs Market Trends
Table 160. Bacteria-derived Microbial Drugs Market Drivers
Table 161. Bacteria-derived Microbial Drugs Market Challenges
Table 162. Bacteria-derived Microbial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bacteria-derived Microbial Drugs
Figure 2. Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bacteria-derived Microbial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Bacteria-derived Microbial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Bacteria-derived Microbial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Bacteria-derived Microbial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Bacteria-derived Microbial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Bacteria-derived Microbial Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Bacteria-derived Microbial Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Bacteria-derived Microbial Drugs Report Years Considered
Figure 18. Bacteria-derived Microbial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Bacteria-derived Microbial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Bacteria-derived Microbial Drugs Players: Market Share by Revenue in Bacteria-derived Microbial Drugs in 2024
Figure 21. Bacteria-derived Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Bacteria-derived Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Bacteria-derived Microbial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Bacteria-derived Microbial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Bacteria-derived Microbial Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Bacteria-derived Microbial Drugs by Type (2020-2031)
Figure 56. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Bacteria-derived Microbial Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Bacteria-derived Microbial Drugs by Application (2020-2031)
Figure 59. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Bacteria-derived Microbial Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Bacteria-derived Microbial Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Bacteria-derived Microbial Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Bacteria-derived Microbial Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Bacteria-derived Microbial Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Bacteria-derived Microbial Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Bacteria-derived Microbial Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Bacteria-derived Microbial Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Bacteria-derived Microbial Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bacteria-derived Microbial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacteria-derived Microbial Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bacteria-derived Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Bacteria-derived Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global Bacteria-derived Microbial Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Bacteria-derived Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global Bacteria-derived Microbial Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Bacteria-derived Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Bacteria-derived Microbial Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Bacteria-derived Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Bacteria-derived Microbial Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Bacteria-derived Microbial Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Bacteria-derived Microbial Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Bacteria-derived Microbial Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Bacteria-derived Microbial Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Bacteria-derived Microbial Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global Bacteria-derived Microbial Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Bacteria-derived Microbial Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Bacteria-derived Microbial Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Bacteria-derived Microbial Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global Bacteria-derived Microbial Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Bacteria-derived Microbial Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Bacteria-derived Microbial Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Bacteria-derived Microbial Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Seres Therapeutics Company Information
Table 71. Seres Therapeutics Description and Business Overview
Table 72. Seres Therapeutics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Seres Therapeutics Bacteria-derived Microbial Drugs Product
Table 74. Seres Therapeutics Recent Developments/Updates
Table 75. Assembly Biosciences Company Information
Table 76. Assembly Biosciences Description and Business Overview
Table 77. Assembly Biosciences Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Assembly Biosciences Bacteria-derived Microbial Drugs Product
Table 79. Assembly Biosciences Recent Developments/Updates
Table 80. Synthetic Biologics Company Information
Table 81. Synthetic Biologics Description and Business Overview
Table 82. Synthetic Biologics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Synthetic Biologics Bacteria-derived Microbial Drugs Product
Table 84. Synthetic Biologics Recent Developments/Updates
Table 85. Interxon Company Information
Table 86. Interxon Description and Business Overview
Table 87. Interxon Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Interxon Bacteria-derived Microbial Drugs Product
Table 89. Interxon Recent Developments/Updates
Table 90. PureTech Company Information
Table 91. PureTech Description and Business Overview
Table 92. PureTech Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. PureTech Bacteria-derived Microbial Drugs Product
Table 94. PureTech Recent Developments/Updates
Table 95. Synlogic Company Information
Table 96. Synlogic Description and Business Overview
Table 97. Synlogic Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Synlogic Bacteria-derived Microbial Drugs Product
Table 99. Synlogic Recent Developments/Updates
Table 100. Enterome BioScience Company Information
Table 101. Enterome BioScience Description and Business Overview
Table 102. Enterome BioScience Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Enterome BioScience Bacteria-derived Microbial Drugs Product
Table 104. Enterome BioScience Recent Developments/Updates
Table 105. 4D Pharma Company Information
Table 106. 4D Pharma Description and Business Overview
Table 107. 4D Pharma Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. 4D Pharma Bacteria-derived Microbial Drugs Product
Table 109. 4D Pharma Recent Developments/Updates
Table 110. Second Genome Company Information
Table 111. Second Genome Description and Business Overview
Table 112. Second Genome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Second Genome Bacteria-derived Microbial Drugs Product
Table 114. Second Genome Recent Developments/Updates
Table 115. AOBiome Company Information
Table 116. AOBiome Description and Business Overview
Table 117. AOBiome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. AOBiome Bacteria-derived Microbial Drugs Product
Table 119. AOBiome Recent Developments/Updates
Table 120. Rebiotix Company Information
Table 121. Rebiotix Description and Business Overview
Table 122. Rebiotix Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Rebiotix Bacteria-derived Microbial Drugs Product
Table 124. Rebiotix Recent Developments/Updates
Table 125. Metabiomics Company Information
Table 126. Metabiomics Description and Business Overview
Table 127. Metabiomics Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Metabiomics Bacteria-derived Microbial Drugs Product
Table 129. Metabiomics Recent Developments/Updates
Table 130. Ritter Pharmaceuticals Company Information
Table 131. Ritter Pharmaceuticals Description and Business Overview
Table 132. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Ritter Pharmaceuticals Bacteria-derived Microbial Drugs Product
Table 134. Ritter Pharmaceuticals Recent Developments/Updates
Table 135. Symberix Company Information
Table 136. Symberix Description and Business Overview
Table 137. Symberix Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Symberix Bacteria-derived Microbial Drugs Product
Table 139. Symberix Recent Developments/Updates
Table 140. OpenBiome Company Information
Table 141. OpenBiome Description and Business Overview
Table 142. OpenBiome Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. OpenBiome Bacteria-derived Microbial Drugs Product
Table 144. OpenBiome Recent Developments/Updates
Table 145. Azitra Company Information
Table 146. Azitra Description and Business Overview
Table 147. Azitra Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Azitra Bacteria-derived Microbial Drugs Product
Table 149. Azitra Recent Developments/Updates
Table 150. Osel Company Information
Table 151. Osel Description and Business Overview
Table 152. Osel Bacteria-derived Microbial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Osel Bacteria-derived Microbial Drugs Product
Table 154. Osel Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Bacteria-derived Microbial Drugs Distributors List
Table 158. Bacteria-derived Microbial Drugs Customers List
Table 159. Bacteria-derived Microbial Drugs Market Trends
Table 160. Bacteria-derived Microbial Drugs Market Drivers
Table 161. Bacteria-derived Microbial Drugs Market Challenges
Table 162. Bacteria-derived Microbial Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Bacteria-derived Microbial Drugs
Figure 2. Global Bacteria-derived Microbial Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Bacteria-derived Microbial Drugs Market Share by Type: 2024 & 2031
Figure 4. Oral Dosage Form Product Picture
Figure 5. Enteric Capsules Product Picture
Figure 6. Global Bacteria-derived Microbial Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Bacteria-derived Microbial Drugs Market Share by Application: 2024 & 2031
Figure 8. Gastrointestinal Disorders
Figure 9. Autoimmune Disorders
Figure 10. Diabetes
Figure 11. Cancer
Figure 12. Others
Figure 13. Global Bacteria-derived Microbial Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Bacteria-derived Microbial Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Bacteria-derived Microbial Drugs Sales (2020-2031) & (K Units)
Figure 16. Global Bacteria-derived Microbial Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Bacteria-derived Microbial Drugs Report Years Considered
Figure 18. Bacteria-derived Microbial Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Bacteria-derived Microbial Drugs Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Bacteria-derived Microbial Drugs Players: Market Share by Revenue in Bacteria-derived Microbial Drugs in 2024
Figure 21. Bacteria-derived Microbial Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Bacteria-derived Microbial Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Bacteria-derived Microbial Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Bacteria-derived Microbial Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 44. Latin America Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Colombia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Bacteria-derived Microbial Drugs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Bacteria-derived Microbial Drugs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Bacteria-derived Microbial Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Bacteria-derived Microbial Drugs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Bacteria-derived Microbial Drugs by Type (2020-2031)
Figure 56. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Bacteria-derived Microbial Drugs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Bacteria-derived Microbial Drugs by Application (2020-2031)
Figure 59. Global Bacteria-derived Microbial Drugs Price (US$/Unit) by Application (2020-2031)
Figure 60. Bacteria-derived Microbial Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232